Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Cash flows from operating activities      
Net income (loss) $ 24,598 $ 45,703  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Provision for loss on receivables 1,883 621  
Depreciation and amortization 926 987  
Amortization of financing costs 3,250 2,716  
Equity-based compensation 7,898 3,540  
Equity method investments (11,415) (38,564)  
Non-cash gain on securitization (6,882) (4,532)  
(Gain) loss on sale of receivables and investments 1,305 29  
Changes in receivables held-for-sale 37,249 (43,482)  
Changes in accounts payable and accrued expenses 936 11,709  
Change in accrued interest on receivables and investments (12,231) (2,925)  
Other 1,287 (7,745)  
Net cash provided by (used in) operating activities 48,804 (31,943)  
Cash flows from investing activities      
Equity method investments (362,831) (78,717)  
Equity method investment distributions received 1,469 4,217  
Proceeds from sales of equity method investments 0 1,700  
Purchases of and investments in receivables (96,842) (35,018)  
Principal collections from receivables 22,741 19,850  
Proceeds from sales of receivables 7,634 0  
Purchases of real estate 0 (4,550)  
Posting of hedge collateral (20,350) 0  
Other (548) (2,975)  
Net cash provided by (used in) investing activities (448,727) (95,493)  
Cash flows from financing activities      
Proceeds from credit facilities 312,000 0  
Principal payments on credit facilities (5,000) 0  
Proceeds from issuance of commercial paper notes 100,000 25,000  
Net proceeds of common stock issuances 23,256 50,011  
Payments of dividends and distributions (35,142) (31,810)  
Withholdings on employee share vesting (1,317) (2,211)  
Payment of financing costs 0 (3,421)  
Other (503) (461)  
Net cash provided by (used in) financing activities 388,154 31,531  
Increase (decrease) in cash, cash equivalents, and restricted cash (11,769) (95,905)  
Cash, cash equivalents, and restricted cash at beginning of period 175,972 251,073 $ 251,073
Cash, cash equivalents, and restricted cash at end of period 164,203 155,168 $ 175,972
Interest paid 20,343 13,145  
Supplemental disclosure of non-cash activity      
Residual assets retained from securitization transactions 5,330 4,532  
Issuance of common stock from conversion of Convertible Notes 0 7,674  
Deconsolidation of non-recourse debt 32,923 0  
Deconsolidation of assets pledged for non-recourse debt 31,371 0  
Non-recourse debt      
Cash flows from financing activities      
Principal payments on non-recourse debt $ (5,140) $ (5,577)